Lannett Company, Inc - LCI

Yahoo! Finance: LCI News

Latest Financial News for Lannett Co Inc Common Stock

• What Investors Think About Lannett (at Motley Fool)

  (Wed, 21 Jul 2010 16:22:59 GMT)

• FDA approves Lannett?s generic for Sandoz weight-loss drug (at bizjournals.com)

  (Tue, 20 Jul 2010 18:05:06 GMT)

• Lannett gets approval for generic obesity drug (AP)

  (Tue, 20 Jul 2010 18:03:22 GMT)

  Lannett Co. said Tuesday it received Food and Drug Administration approval for a generic version of the obesity drug phentermine.

• Lannett Receives FDA Approval for Phentermine Hydrochloride Capsules USP 30 mg (Business Wire)

  (Tue, 20 Jul 2010 16:53:00 GMT)

  PHILADELPHIA----Lannett Company, Inc. today announced that it has received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application for Phentermine Hydrochloride Blue/White Seed Capsules USP, 30 mg, the generic equivalent of Sandoz, Inc.?s Reference Listed Drug Phentermine Hydrochloride Capsules USP, 30 mg.

• Lannett to Present at Jefferies 2010 Global Life Sciences Conference (Business Wire)

  (Wed, 02 Jun 2010 12:00:00 GMT)

  PHILADELPHIA----Lannett Company, Inc. today announced that Arthur Bedrosian, president and chief executive officer, will present a company overview at the Jefferies 2010 Global Life Sciences Conference at The Grand Hyatt Hotel in New York City on Wednesday, June 9th at 10:30 a.m.

• LANNETT CO INC Financials (EDGAR Online Financials)

  (Fri, 21 May 2010 17:04:39 GMT)

• LANNETT CO INC Files SEC form 8-K, Results of Operations and Financial Condition (EDGAR Online)

  (Fri, 14 May 2010 17:16:39 GMT)

• LANNETT CO INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)

  (Thu, 13 May 2010 20:44:16 GMT)

• Lannett Reports Fiscal 2010 Third Quarter Financial Results (Business Wire)

  (Wed, 12 May 2010 18:30:00 GMT)

  PHILADELPHIA----Lannett Company, Inc. today reported financial results for the fiscal 2010 third quarter and nine months ended March 31, 2010.

• Q3 2010 Lannett Company, Inc. Earnings Release - Time Not Supplied (CCBN)

  (Wed, 12 May 2010 11:07:26 GMT)

Yahoo! Finance: RSS feed not found

Yahoo! Finance: RSS feed not found

• Yahoo! Finance: RSS feed not found

  ()

  RSS feed not found. Please remove this RSS feed or check Yahoo! Finance for more symbols.

MSN Money News - LCI

News about Lannett Co Inc

• What Investors Think About Lannett

  (Wednesday, July 21, 2010 9:33 AM)

  Take the temperature of your stock. 2010 07 21 09:33

• Lannett Receives FDA Approval for Phentermine Hydrochloride Capsules USP 30 mg

  (Tuesday, July 20, 2010 12:53 PM)

  Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Phentermine 2010 07 20 12:53

• Market Report -- In Play (LCI)

  (Tuesday, July 20, 2010 12:53 PM)

  Lannett receives FDA approval for Phentermine Hydrochloride Capsules Co announced that it has received approval from the FDA of its Abbreviated New Drug Application for Phentermine Hydrochloride 2010 07 20 12:53

• Lannett to Present at Jefferies 2010 Global Life Sciences Conference

  (Wednesday, June 02, 2010 8:00 AM)

  Lannett Company, Inc. (NYSE AMEX: LCI) today announced that Arthur Bedrosian, president and chief executive officer, will present a company overview at the Jefferies 2010 Global Life Sciences 2010 06 02 08:00

• Lannett Reports Fiscal 2010 Third Quarter Financial Results

  (Wednesday, May 12, 2010 2:30 PM)

  Lannett Company, Inc. (NYSE AMEX: LCI) today reported financial results for the fiscal 2010 third quarter and nine months ended March 31, 2010. For the third quarter of fiscal 2010, net sales 2010 05 12 14:30

• Lannett Company to Report Fiscal 2010 Third-Quarter Financial Results and Host Conference Call on Wednesday, May 12

  (Wednesday, May 05, 2010 1:42 PM)

  Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that the company will release its fiscal 2010 third-quarter financial results on Wednesday, May 12, 2010 05 05 13:42

LCI - News and Analysis from Seeking Alpha

'LCI' Tag RSS Syndication from SeekingAlpha.com

• Big Lineup of Healthcare Stocks Crack the Russell 3000 Index

  (Wed, 01 Jul 2009 07:53:52 -0400)

  M.E. Garza submits:

  It’s official, the new list of Russell 3000® stocks has been unveiled and a big lineup of healthcare sector companies who were looking to bring value to their shareholders and expose their stocks to a broader base of institutional investors have succeeded.

  Certainly, speaking to the growth of the sector was the fact that nearly six times more stocks were added to the list from the BioMed/Healthcare segment of the market than were deleted.

  
  Complete Story »

• 20 Bullish Stocks, 2 Detailed Trades

  (Tue, 30 Jun 2009 09:00:03 -0400)

  Marco Anthony submits:

  Here is an updated list of stocks which are demonstrating strong technicals. In this list of 20 stocks there does not seem to be a specific trend among the stocks, like last week's, which were mostly from the healthcare sector.

  The ratio used in the table below is the Bull to Bear ratio. This is a list of criteria I screen for to find stocks that are potential breakouts. Recently by using this method I was able to make very good trading profits by finding breakout patterns on specific stocks like Joy Global (

• Caraco Pharma Poised for a Turnaround

  (Sat, 30 May 2009 15:12:15 -0400)

  Mike Havrilla submits:

  On 5/28/09, Caraco Pharma (AMEX:CPD) reported its fiscal year 2009 (FY09) results and provided an update on the status of a recently completed FDA inspection of the Company's manufacturing facilities in Detroit, MI. Net sales for CPD declined by 4% for FY09 to a level of $337.2M (versus $350.4M for FY08). The Company cited lower sales of its manufactured products, price erosion for both manufactured + distributed generic drugs, and a voluntary product recall (of heart drug digoxin) during late FY09 for the revenue shortfall.

  

• Biotech Going Generic Like Big Pharma?

  (Mon, 02 Mar 2009 16:15:30 -0500)

  Mike Havrilla submits:

  Sanofi-Aventis (SNY) is now the 11^th largest generic drug maker in the world following its successful acquisition of Czech generic drug company Zentiva. As $70B in brand drug patents are set to expire through 2012, big pharma companies are hedging their bets through generic drug divisions, including Pfizer (PFE) - Greenstone, Novartis (NVS) - Sandoz, and the recently announced Merck (MRK) BioVentures which will specialize in bio-generics.

  Elsewhere in the industry, India-based Ranbaxy (RANBAXY.NS) lost about...

• A 130/30 Generic Pharma Trading Strategy

  (Tue, 24 Feb 2009 03:22:07 -0500)

  Mike Havrilla submits:

  The accompanying tables include 12 U.S. listed companies from the ETF Innovators Global Generic Drug Index along with eight brand name drug companies, which are ranked in descending order based on their patent expiration exposure through the end of 2011 as a percentage of total trailing 12-month revenue.
  
  Investors who are bullish on the generic drug industry may consider implementing a 130/30 pharma trade by shorting any/all of the top seven brand drug companies by patent expiration exposure with 30% of their assets while investing 130% of assets in long positions among generic drug makers.
  
  Complete Story »

• Commodities, Roll Yield and Contango

  (Mon, 31 Mar 2008 02:06:01 -0400)

  Hard Assets Investor submits:

  Investing in commodities means investing in futures. And futures mean the mysteries of contango and backwardation. We cover this all the time here at HardAssetsInvestor.com, and with good reason. Rolling forward a futures contract can be a tremendous source of loss or gain for an investor, often overwhelming the returns that changes in spot price might imply.

  Usually, we?re worried about contango ? the crippling headwind faced by most commodities these days, where it costs more to buy next month?s contract than it does today?s. The effect on indexes has been so pronounced that many firms...

News for Lannett Company, Inc. - Google Finance

News for Lannett Company, Inc. - Google Finance

• What Investors Think About Lannett

  (Wed, 21 Jul 2010 18:56:08 GMT)
  What Investors Think About Lannett
  The Money Times - Jul 21, 2010

  by Motley Fool - July 22, 2010 - 0 comments Together, we are all trying to build our fortune by finding well-run companies at bargain-basement prices. But it takes work -- scouring company ...

• Lannett Receives FDA Approval for Phentermine Hydrochloride Capsules USP 30 mg

  (Tue, 20 Jul 2010 16:55:14 GMT)
  Lannett Receives FDA Approval for Phentermine Hydrochloride Capsules USP 30 mg
  Business Wire - Jul 20, 2010

  PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has received approval from the US Food and Drug Administration (FDA) of its Abbreviated New Drug ...

  Lannett's ANDA for Phentermine Hydrochloride Blue/White Seed Capsules receives FDA approval - News-Medical.net
  

• Lannett Company, Inc. Receives FDA Approval For Phentermine Hydrochloride Capsules USP 30 mg

  (Tue, 20 Jul 2010 16:53:00 GMT)
  Lannett Company, Inc. Receives FDA Approval For Phentermine Hydrochloride Capsules USP 30 mg
  Reuters Key Development - Jul 20, 2010

• Lannett to Address Jefferies 2010 Global Life Sciences Conference

  (Fri, 04 Jun 2010 04:47:36 GMT)
  Lannett to Address Jefferies 2010 Global Life Sciences Conference
  Trading Markets - Jun 4, 2010

  Lannett Company, Inc. announced that Arthur Bedrosian, president and chief executive officer, will present a company overview at the Jefferies 2010 Global Life Sciences Conference at The Grand ...

• Lannett to Present at Jefferies 2010 Global Life Sciences Conference

  (Wed, 02 Jun 2010 12:01:42 GMT)
  Lannett to Present at Jefferies 2010 Global Life Sciences Conference
  Business Wire - Jun 2, 2010

  PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (NYSE AMEX: LCI) today announced that Arthur Bedrosian, president and chief executive officer, will present a company overview at the Jefferies ...

• Lannett Company, Inc. (LCI) Corporate Event Announcement Notice

  (Fri, 28 May 2010 01:02:54 GMT)
  Lannett Company, Inc. (LCI) Corporate Event Announcement Notice
  Trading Markets - May 28, 2010

  For full details on Lannett Co Inc (LCI) LCI. Lannett Co Inc (LCI) has Short Term PowerRatings at TradingMarkets. Details on Lannett Co Inc (LCI) Short Term PowerRatings is available at This Link ...

• Lannett Reports Fiscal 2010 Third Quarter Financial Results

  (Wed, 12 May 2010 18:31:11 GMT)
  Lannett Reports Fiscal 2010 Third Quarter Financial Results
  Business Wire - May 12, 2010

  PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (NYSE AMEX: LCI) today reported financial results for the fiscal 2010 third quarter and nine months ended March 31, 2010. For the third quarter ...

• Lannett Company to Report Fiscal 2010 Third-Quarter Financial Results and Host Conference Call on Wednesday, May 12

  (Wed, 05 May 2010 17:43:52 GMT)
  Lannett Company to Report Fiscal 2010 Third-Quarter Financial Results and Host Conference Call on Wednesday, May 12
  Business Wire - May 5, 2010

  PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that the company will release its fiscal 2010 third-quarter ...

• Thursday earnings spotlight on POZEN, Inc.; POZN, DEPO, LCI, NVO

  (Wed, 28 Apr 2010 16:27:31 GMT)
  Thursday earnings spotlight on POZEN, Inc.; POZN, DEPO, LCI, NVO
  Learning Markets - Apr 28, 2010

  Investors watch earnings releases keenly, as changes in a company's performance can be a good indication whether a company is on the right track, or headed the wrong way. POZEN, Inc. (NASDAQ:POZN ...

• Lannett Company, Inc. Receives FDA Approval For Ondansetron Injection, USP 2 mg/mL Multi Dose Vials

  (Mon, 19 Apr 2010 17:46:00 GMT)
  Lannett Company, Inc. Receives FDA Approval For Ondansetron Injection, USP 2 mg/mL Multi Dose Vials
  Reuters Key Development - Apr 19, 2010

Only registered users can write comments.
Please login or register.